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Abstract 
 
Objectives: The aim of this study was to compare long-term outcomes of 
implants placed both in patients treated for periodontitis and in periodontally 
healthy patients (PHP). 
Material and methods: One hundred and twelve partially edentulous patients 
were consecutively enrolled in private specialist practice and divided in 3 
groups according to their initial periodontal condition: PHP, moderately 
Periodontally Compromised Patients (PCP) and severely PCP. Implants were 
placed to support fixed prostheses, after successful completion of initial 
periodontal therapy [full-mouth plaque score (FMPS)<25%, full-mouth 
bleeding score (FMBS) <25%]. At the end of active periodontal treatment 
(APT), patients were asked to follow an individualized Supportive Periodontal 
Therapy (SPT) program. Diagnosis and treatment of peri-implant biological 
complications was performed according to Cumulative Interceptive Supportive 
Therapy (CIST). At 10 years, clinical measures were recorded by two 
calibrated operators, blind to the initial patient classification, on 101 patients, 
as 11 were lost to follow-up. The number of sites treated according to therapy 
modalities C and D (antibiotics and/or surgery) during the 10 years was 
registered. 
Results: Eighteen implants were removed for biological complications. 
Antibiotic and/or surgical therapy was performed in 10.7 % of cases in PHP, 
in 27 % of cases in moderate PCP and in 47.2% cases in severe PCP, with a 
statistically significant differences between PHP and severe PCP (p =0.002). 
At the final examination, the percentage of implants, with at least one site 
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which presented a PD ≥ 6 mm, was respectively 1.7 % for PHP, 15.9% for 
moderate PCP and 27.2% for severe PCP, with a statistically significant 
difference between PHP and moderate PCP(p =0.005) and PHP and severe 
PCP (p =0.0001).  
Conclusion: Patients with a history of periodontitis presented a statistically 
significant higher number of sites which required additional treatment. 
Therefore, patients with a history of periodontitis should be informed that they 
are more at risk for peri-implant disease. This underlines the value of the SPT 
in enhancing long term outcomes of implant therapy, particularly in subjects 
affected by periodontitis. Moreover, the approach for multiple preventive 
dental extractions and implant placement, based on the assumption the 
implants perform better than teeth, should be followed with extreme 
caution.
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Introduction 
 During the last decades, the use of dental implants for replacement of 
missing teeth has become a routine procedure also in the rehabilitation of the 
periodontally compromised patients (PCP), even though biological 
complications are underreported (Berglundh et al. 2002) as the prognosis of 
implant treatment is often reported as survival rates. In a previous publication 
on the material included in this paper, solid screws 10-year survival rate 
varied from 98% in periodontally healthy subjects (PHP) to 90% in severe 
PCP (Roccuzzo et al. 2010). Moreover, the lack of adhesion to SPT was 
associated with a higher incidence of bone loss and implant loss. These 
results are in concordance with other recent long-term studies (Tomasi et al. 
2008, De Boever et al. 2009, Matarasso et al. 2010, Schmidlin et al. 2010). 
Nevertheless, in order to better describe the outcomes of implant treatment, 
the clinical condition around these implants has to be presented (Romeo et al. 
2005; Roos-Jansåker et al. 2006, De Boever et al. 2009, Rinke et al. 2010).   
Dentitions damaged by severe periodontal disease often cause problems not 
only to the patient but also to the dentist, in particular regarding the choice of 
therapy, i.e. to save or to extract (Lundgren et al. 2008). Some may insinuate 
that dentists are avoiding traditional periodontal therapy in favour of extracting 
teeth and replacing them with dental implants, based on the assumption the 
implants perform better than teeth. Nevertheless, the Consensus Report of 
6th European Workshop on Periodontology (Lindhe & Meyle 2008) suggested 
a high incidence of peri-implant diseases with mucositis in about 80% of 
subjects restored with implants, and peri-implantitis in between 28% and 56% 
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of subjects. A similar frequency of complications was also reported by Rinke 
et al. (2010) in a recent practice-based cross-sectional study.  
 The aim of this study was to prospectively assess the 10-year results of 
implant therapy in a group of PHP compared to a group of PCP of both 
moderate and severe grade. Results regarding per-implant pockets, plaque 
and bleeding on probing around implants and number of teeth lost are 
described in this article. 
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Material and methods 
Study population 
 All patients attending the principle investigator (M.R.), a specialist in 
periodontology, for dental implant therapy between May 15, 1996 and May 
15, 1998 were screened for possible inclusion in the study.  
Exclusion criteria were:  
(1) complete edentulism;  
(2) presence of dental implants;  
(3) mucosal diseases;  
(4) alcohol and drug abuse;  
(5) pregnancy;  
(6) uncontrolled metabolic disorders;  
(7) aggressive periodontitis;  
(8) no interest in participating into the study.  
Patients were informed that their data would be used for statistical analysis 
and gave their informed consent to the treatment. The study was performed in 
accordance with the principles stated in the Declaration of Helsinki.  
 
Pre-treatment clinical examination 
 Gender, date of birth, smoking habits, medical history at the time of the 
initial visit and treatment planning were obtained. Moreover, subjects were 
clinically and radiographically monitored at baseline. Full mouth plaque score 
(FMPS), full mouth bleeding score (FMBS) and pocket depth (PD) were 
measured at 4 sites per tooth for all teeth by means of a periodontal probe 
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(XP23/UNC 15, Hu-Friedy, Chicago, USA), and rounded off to the nearest 
millimeter 
 At the baseline, 3 groups were formed on the basis of the clinical 
diagnosis: 
PHP: periodontally healthy patients; 
PCP: periodontally compromised patients. 
Moreover, PCP received a score (S) on the basis of the number and depth of 
periodontal pockets according to the following formula: 
S = Number of pockets (5-7mm) + 2 Number of pockets (>8 mm)   
These patients were further divided in 2 groups: 
Moderate PCP: periodontally compromised patients with S < 25 
Severe PCP:  periodontally compromised patients with S > 25. 
 
Periodontal therapy  
 Following selection, all patients received appropriate initial therapy, 
consisting, depending on the cases, in motivation, oral hygiene instruction 
and scaling and root planning, with the aim to reduce to a minimal level 
periodontal pathogens. Hopeless teeth were recorded and extracted. 
Periodontal surgery was performed as needed after re-evaluation. Guided 
tissue regeneration was pursued, when feasible. Individual treatment was 
thoroughly discussed with the patients and established according to their 
personal need and desire. No implant surgery was performed before the 
assurance of good motivation and compliance from each single patient 
(FMPS<25%; FMBS<25%). 
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Implant placement and prosthetic reconstruction 
 TPS dental implants (Institut Straumann AG, Waldenburg, Switzerland) 
were placed, under local anesthesia, by the same operator (MR), according to 
the manufacturer’s instructions. Full body screws, hollow screws and hollow 
cylinders were used, 8, 10 and 12 mm long, 3.3, 4.1 and 4.8 mm in diameter. 
All implants were placed using a standardized surgical procedure (Buser et al. 
2000). The implants were placed with the border of the rough surface 
approximating the alveolar bone crest leaving the machined neck portion in 
the transmucosal area. Implants that required bone augmentation and/or 
sinus lift elevation were not included in the study.  
If necessary, an excision of soft tissue was performed in order to allow a 
close adaptation of the wound margins to the implant shoulder without 
submerging it. The number, position and type of implants in each patient were 
determined after a thorough diagnosis of the anticipated needs for the 
planned prosthesis and the presence of anatomic limitations. 
Appropriate healing screws were placed on top of the implants and the flaps 
were sutured, in a non-submerged fashion.  Abutment connection was carried 
out at 35 Ncm 3-6 months postsurgery, by the same operator. Abutments for 
cemented restoration were selected according to the intermaxillary space. All 
patients were provided with implant-supported fixed restorations. All 
restorations were fabricated in order to facilitate both the oral hygiene 
procedures and the probing along their circumference. Baseline probing 
measurements were also recorded around the implants. 
 
Follow up 
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 Patients were recalled at various intervals, depending on the initial 
diagnosis and the results of the therapy, for supporting periodontal therapy 
(SPT). Motivation, reinstruction, instrumentation and treatment of re-infected 
sites were performed as needed.  Patients were placed on an individually 
tailored maintenance care program, including continuous evaluation of the 
occurrence and the risk of disease progression. If a patient expressed the 
desire not to attend follow-up examinations, he/she was classified as “drop-
out”. The diagnosis and treatment of peri-implant biological complications was 
performed according to Cumulative Interceptive Supportive Therapy (CIST) 
(Mombelli & Lang 1998). Depending on the circumstances patients were 
given: (A) Mechanical cleansing and improvement of patient’s oral hygiene. 
Removal of hard deposits with soft scalers, polishing with rubber cup and 
paste. Instruction for more effective oral hygiene practices; (B) Antiseptic 
therapy with chlorhexidine digluconate or local application of chlorhexidine gel 
(C) Systemic antibiotic therapy or treatment with local delivery device. (D) 
Surgical therapy; (E) Explantation. The number of sites treated according to 
therapy modalities C and D (antibiotics and/or surgery) during the 10 years 
was also registered. 
Final clinical examination 
 After 10 years two calibrated examiners, blinded to the initial 
classification of the patients, recorded, for each test implant, probing depth 
(PD) measured at four sites (mesial, buccal, distal and lingual) by means of a 
periodontal probe (XP23/UNC 15,  Hu-Friedy, Chicago, USA), and rounded 
off to the nearest millimeter.   
At the same time the following parameters were collected:  
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 Implant loss: the time in months for any implant lost; 
 plaque score (presence/absence): total score for both teeth and 
implants (FMPS) and for implants alone (Pl), measured at four sites 
per tooth and implant and expressed as a percentage of examined 
sites; 
 bleeding on probing score (presence/absence): total score for both 
teeth and implants (FMBS) and for implants alone (BOP), measured at 
four sites per tooth and implant and expressed as a percentage of 
examined sites; 
 smoking habits; 
 number of missing teeth at baseline; 
 number of extracted  teeth during Active Periodontal Therapy (APT); 
 number of lost teeth during SPT; 
 Complete adhesion to the SPT (yes or no);  
 Deepest PD during the SPT;  
 Deepest PD at 10-year follow-up; 
 number of patients, who required, during the SPT, either C or D 
therapy modality. 
 
Statistical analysis 
 Data were expressed as mean ± SD or counts and percentages. 
Qualitative data were analyzed by means of Chi-square or Fisher’s exact test. 
The normality assumption of the quantitative measures was verified by 
Shapiro-Wilk test and significance of between-group differences were 
assessed using Kruskal Wallis rank test. Pairwise comparisons of the groups 
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were performed by Mann-Whitney test with Bonferroni’s adjustment for 
multiple comparisons. All the tests were two tailed with a significance level set 
at 5%. 
 
Results 
 
The general characteristics of the population of the present study have been 
described in a previous publication (Roccuzzo et al. 2010). Briefly, out of the 
initial 112 patients enrolled in the study, 11 patients did not attend the final 
examination. Four patients had died, three had moved and 4 patients did not 
wish to participate or were unable to attend because of severe health 
problems. Thus, this report includes a study group of 101 individuals: 28 PHP, 
37 moderate PCP and 36 severe PCP. No inter-group differences for age, 
gender, implant type, number of teeth lost during the follow-up and 
acceptance of SPT were found. Only a small portion of the subjects were 
smokers: 3 (11.1%) in the PHP, 10 (27%) in the moderate PCP and 5 (13.9%) 
in the severe PCP, with no significant difference among the groups.  
The 101 patients, who attended the 10-year examination, received a total of 
246 implants. Two out of 61 (3.4%) implants were lost in PHP, seven out of 
95 (7.2%) in moderate PCP and nine out of 90 (10%) in severe PCP (Table 
1). 
At the initial examination, 8.0 (± 4.7), 9.6 (± 5.9) and 6.4 (± 3.2) teeth per 
patient were missing in the PHP, moderate PCP and severe PCP groups, 
respectively. During the therapy preceding implant surgery, 280 teeth (11.6% 
of the total 2423 teeth present at the initial examination) were extracted. A 
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mean of 1.7 ±  2.0 teeth were extracted in the PHP group, 2.1 ±  2.2 in the 
moderate PCP group and 4.3 ± 2.8 in severe PCP group. The difference 
between severe PCP and PHP and between severe PCP and moderate PCP 
were statistically significant (p=0.0001 and 0.0003, respectively). No 
difference was found between PHP and moderate PCP(Table 1). 
During the 10-year SPT, 129 teeth (6.0% of the total 2143 teeth) were lost for 
various reasons. In particular, 26 teeth (4.2% of 624 teeth) were lost in PHP, 
49 (6.5% of 753) in moderate, and 54 (7% of 766) in severe. The 
corresponding mean number of teeth lost per patient was therefore, 
respectively, 0.9 ± 1.2 for PHP, 1.3 ± 1.6 for moderate, and 1.5 ± 1.7 for 
severe. The differences did not reach a statistical significant difference (Table 
1). 
The mean plaque score around the implants still present at the 10-year 
examination was 16.1 ± 2.4%, 29.0 ± 2.4% and 23.1 ± 2.3% for PHP, 
moderate PCP and severe PCP, respectively. A statistically significant 
difference was found between PHP and severe PCP (p=0.0003) (Table 2). 
The mean BOP was 12.3 ± 2.1% in PHP, 31.0 ± 2.5% in moderate PCP and 
30.9 ± 2.6% in severe PCP. A statistically significant difference was found 
between PHP and both moderate and severe PCP (p=0.0001) (Table 2).  
The mean PD at the 10-year examination was 3.1 ± 0.5 mm, 3.5 ± 0.9 mm 
and 3.9 ± 0.7 mm for PHP, moderate PCP and severe PCP. Only the 
difference between PHP and severe PCP reached the statistic significance 
(P=0.0000) (Table 2). 
Biological complications occurred in all the three groups during the 10-year 
observation period. 
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Due to periimplantitis, 10.7% of patients in the PHP, 27% in the moderate 
PCP and 47.2% in the severe PCP group received treatment C or D of the 
CIST protocol. A statistical significant difference was found comparing PHP 
and severe PCP (p=0.002) (Table 3). 
Considering only the deepest PD measured around implants during the SPT, 
the mean deepest PD was 4.2 ± 1.1 mm in PHP, 5.1 ± 1.8 mm in moderate 
PCP and 5.5 ± 1.7 mm in severe PCP. Both PCP groups showed a 
statistically higher mean deepest PD compared to PHP (PHP versus 
moderate PCP: p=0.001; PHP versus severe PCP: p=0.0001). The difference 
between moderate and severe PCP was also statistically significant 
(p=0.016). 
The mean deepest PD around implants recorded at the 10-year follow-up 
examination was 3.9 ± 0.7 mm, 4.4 ± 1.1 mm and 4.8 ± 1.2 mm for PHP, 
moderate PCP and severe PCP, respectively. Again, differences between the 
three groups were statistical significant (PHP versus moderate PCP: p=0.015; 
PHP versus severe PCP: p=0.0001; moderate versus severe PCP: p=0.009) 
(Table 3a). 
In PHP, 6.6% of the implants displayed a PD > 6mm during SPT. The 
corresponding values were 29.5% for moderate PCP and 45.6% severe PCP. 
The differences between PHP and both moderate (p=0.0005) and severe 
PCP (p=0.0001) groups were statistically significant, whereas the difference 
between moderate and severe PCP was not (Table 3a). 
 At the 10-year examination, 1.7%, 15.9% and 27.2% of the survived implants 
displayed a PD > 6 mm. Again, only the differences between PHP and the 
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PCP groups were statistically significant (PHP versus moderate PCP: 
p=0.0005; PHP versus severe PCP: p=0.0001) (Table 3). 
Four patients in the PHP group, 11 in the moderate PCP and 7 patient in the 
severe PCP group did not completely adhere to SPT.  
At the 10-year examination, a significant difference was found between 
moderate PCP adhering and not adhering to SPT concerning PI (25 ± 2.7% 
versus 38.5 ± 4.8%; p=0.011), BOP (23 ± 2.7% versus 50 ± 4.9%; p=0.0001) 
and PD (3.2 ± 0.6 versus 4.3 ± 1.2; p=0.008) (Table 4). 
In the severe PCP group, significant differences were found for the PI (20.3 ± 
2.4% versus 39.6 ± 7.1%; p=0.003) and the BOP (27.2 ± 2.7% versus 52.1 ± 
7.2%: p=0.0006) comparing subjects who adhered or not to SPT (Table 4). 
No statistically significant difference was recorded concerning the number of 
teeth lost during SPT (Table 4) and the percentage of patients who 
undergone treatment C or D due to peri-implant biological complications. 
On the contrary, statistically significant differences were revealed both in 
moderate PCP and severe PCP for the deepest PD during SPT (4.5 ± 1.3 
versus 6.3 ± 2.0: p= 0.0001; 5.1 ± 1.4 versus 7.2 ± 1.8: p=0.0001), the 
deepest PD at 10-year (4.0 ± 0.8 versus 5.2 ± 1.3: p= 0.0001; 4.7 ± 1.2 
versus 5.7 ± 1.1: p=0.009), the percentage of implants with deepest PD ≥ 
6mm during SPT (15.6% versus 58.1%: p= 0.001; 34.7% versus 88.9%: 
p=0.001)  and the percentage of implants with deepest PD ≥ 6mm at 10-year 
(4.8% versus 42.3%: p= 0.001; 21.7% versus 58.3%: p=0.01) between the 
patients who adhered and the ones who didn’t to SPT (Table 5). No statistical 
significant differences were found for any of the observed variables in the 
PHP group (Table 4 and 5). 
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Discussion 
 The question if patients with a history of periodontitis are more at risk 
for peri-implant disease has received increasing attention in the last years. 
Since the publication of the first part of the present research (Roccuzzo et al. 
2010), several studies, most of them retrospective, have been published on 
this topic (Gianserra et al. 2010, Matarasso et al. 2010, Schmidlin et al. 2010, 
Simonis et al. 2010, Wahlström et al. 2010, Aglietta et al. 2011, Brägger et al. 
2011). The vast majority of these papers concluded that implants in PCP 
yielded lower survival rates and higher mean marginal BL rates compared 
with those of implants placed in PHP.  
In apparent contrast with these results, Wahlström et al. (2010) concluded 
that, in the short term, overloading and bruxism seem more hazardous for 
implant treatment, compared with a history of periodontitis. Similarly,  
Gianserra et al. (2010) stated, in a 5-year multicentre retrospective cohort 
study of 1727 patients, that a previous history of periodontal disease may not 
have a significant impact on implant failures up to 5 years after loading. 
These results may underestimate the value of the SPT in enhancing long 
term outcomes of implant therapy, particularly in subjects affected by severe 
periodontitis. It must be noted, however, that owing to the retrospective nature 
of the studies, these conclusions need to be interpreted with extreme caution. 
Moreover, the Kaplan-Meier analysis, presented in the first part of our 
research, clearly shows that the difference between PHP and PCP is 
negligible during the first 5 years, but becomes more pronounced later on. 
Our results are in accordance with the findings of Karoussis et al. (2003) who 
first demonstrated that a 5-year follow-up is usually not sufficient to evaluate 
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the differences in the clinical outcomes of the  various groups of patients. The 
need for prospective observational studies was presented by a recent 
systematic review (Safii et al. 2010) based on the evidence that periodontitis 
subjects are at significantly higher risk for implant failure and greater marginal 
bone loss as compared with periodontally healthy subjects.The results of this 
research compare well with a similar recent study  (De Boever et al. 2009) 
with a similar implant maintenance protocols. One limit to the statistical 
analysis of the present study is that, when several implants are placed 
dependent data are observed. Ideally, each patient should be the 
statistical independent unit.  
There are opinions among clinicians that the prognosis of complex 
periodontal therapy may not match the high levels of success of treatment 
with implants. As a consequence more and more teeth are extracted on the 
assumptions that implants perform better than periodontally compromised 
teeth and that their longevity is independent of the individual’s susceptibility to 
periodontitis (Lundren et al. 2008). In reality, during the 10-year SPT, 129 
teeth were extracted, corresponding to 6.0 % of the 2143 teeth. The 
corresponding mean number of teeth lost per patient was 0.9 + 1.2 for PHP, 
1.3 + 1.6 for moderate PCP and 1.5 + 1.7 for severe PCP, with no significant 
difference among the three groups. It is important to note that in this analysis 
third molars were also included similarly to Tonetti et al. (1998) and Ng et al. 
(2011) and that the number of teeth that were extracted was reported, 
regardless of the clinician providing the service and the reason for the 
extraction. This may reduce the differences among the groups. Other authors, 
McLeod et al. (1997), Tonetti et al. (2000) Checchi et al. (2002), Pretzl et al. 
  18 
(2008), Matuliene et al. (2010), Martin et al. (2010) Miyamoto et al. (2010) 
have instead included only non-third molars. Nevertheless these preliminary 
results seem not to support a frequent current approach for multiple 
preventive dental extractions and implant placement based on the 
assumption the implants perform better than teeth. 
The number of implants with a PD ≥ 6mm varied among the 3 groups, both 
during the entire period of SPT and at the time of final 10-year examination. 
The differences were statistically significant between PHP and both PCP 
(Table 3a). Our data support the need for a SPT where clinical and 
radiographic parameters should be re-assessed at every follow-up visit in 
order to detect peri-implant infections as early as possible and to intercept the 
problems with appropriate therapy (Mombelli & Lang 1998). 
 According to the Sixth European Workshop on Periodontology peri-
implant mucositis describes an inflammatory lesion that resides in the 
mucosa, while periimplantitis also affects the supporting bone (Lindhe & 
Meyle 2008). While these definitions are considered adequate, the diagnostic 
criteria for them are less clear. Based on longitudinal clinical studies the 
Seventh EWP (Lang & Berglundh 2011) suggested that the time of prosthesis 
installation should be chosen to establish baseline criteria representing 
homeostasis following implant installation with or without subsequent 
abutment connection. To establish baseline, a radiograph should be obtained 
to determine alveolar bone levels after physiologic remodelling, and peri-
implant probing assessments performed.  
During the period of observation, 18 implants were removed for 
biological complications. Antibiotic and/or surgical therapy was performed in 
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10.7 % of cases in PHP, in 27 % of cases in moderate PCP and in 47.2% 
cases in severe PCP, with a statistically significant differences between PHP 
and severe PCP (p =0.002). It must be noted, however, that implants 
presented a TPS surface, which was a common surface over a decade ago. 
Later on, new surfaces, such as  sandblasted and acid-etched (SLA), were 
introduced. The minor micro-roughness should be particularly important in 
PCP, since it is suggested that peri-implantitis is influenced by surface 
characteristics. (Berglundh et al. 2007, Albouy et al. 2008, Albouy et al. 
2009). A new investigation is currently in progress to assess the long-term 
clinical and radiographic results around solid screws SLA implants, placed in 
patients with excellent compliance (FMPS<15%) and to compare the results 
with the ones obtained in the present research. 
In accordance with Lundgren et al. (2008), good long-term prognosis in the 
management of periodontitis-affected patients is plaque control efficient 
enough to maintain healthy periodontal tissues. In the same way, a central 
part of implant therapy should be adequate infection control around implants 
to maintain healthy peri-implant tissues. It is important to encourage dental 
teams to take the responsibility of carefully monitoring the treated patients 
and carrying out measures to prevent and treat periodontal or peri-implant 
lesions that may occur ⁄ re-occur. It is also relevant to prepare patients to 
comply with the necessary measures to ensure a good long-term prognosis 
for the treatment provided.  
 In conclusion, patients with a history of periodontitis should be 
informed that they are at higher risk for peri-implant disease. Moreover, 
patients have to be strongly motivated to strictly adhere to SPT as it has 
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proven to be a key factor in enhancing long term outcomes of implant therapy 
by controlling re-infection. Finally, the approach for multiple preventive 
dental extractions and implant placement, based on the assumption the 
implants perform better than teeth, should request extreme caution. 
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Table 1.   Number of implants at baseline and lost during Supportive Periodontal Therapy (SPT);  
Mean number of teeth missing at baseline, extracted during Active Periodontal Therapy (APT) and during SPT.  
 
 
 
Implants  
at baseline 
Implants 
lost during 
SPT 
Teeth 
missing at 
baseline 
Teeth  
extracted in 
APT 
Teeth  
lost during 
SPT 
PHP 61 2 8.0 ± 4.7 1.7 ± 2.0  0.9 ± 1.2 
Moderate PCP 95 7 
 
9.6 ± 5.9 2.1 ± 2.2  1.3 ± 1.6 
Severe PCP 90 9 
 
6.4 ± 3.2 4.3 ± 2.8  1.5 ± 1.7 
 
Statistical difference between: 
PHP-moderate PCP 
PHP-severe PCP 
Moderate PCP-severe PCP 
 
  
 
p=0.48 
p=0.20 
p=0.61 
 
 
p= 0.3098 
p= 0.1177 
p= 0.0146 
 
 
 
p= 0.6723 
p= 0.0001 
p= 0.0003 
 
 
p=0.2170 
p=0.1769 
p=0.7695 
  
Table 2.   Clinical parameters around the implants at the 10-year follow-up  
Pl= plaque score (presence of dental plaque);  
BOP= presence of bleeding on probing;  
PD= probing depth. 
 
 
 
 Pl at 10-year 
 
BOP at 10-year 
 
PD at 10-year 
(mm) 
PHP 
 
16.1 ± 2.4% 
 
 
12.3 ± 2.1% 3.1 ± 0.5 
Moderate PCP 
29 ± 2.4% 
 
31 ± 2.5% 
 
3.5 ± 0.9 
Severe PCP 
23.1 ± 2.3% 
 
30.9 ± 2.6% 
 
3.9 ± 0.7 
 
Statistical difference between 
PHP-moderate PCP 
PHP-severe PCP 
Moderate PCP-severe PCP 
 
 
 
p=0.0003 
p=0.04  
p=0.09 
 
 
p=0.0001 
p=0.0001 
p=0.98 
 
 
p= 0.0626 
p= 0.0000 
p= 0.0319 
 
 
 Table 3a.  Number of patients treated with CIST C/D, deepest PD around implants and percentage of implants  
with deepest PD > 6mm (CIST= cumulative interceptive supportive therapy).  
 
 
 
Patients  
at 
baseline 
Patients 
drop-out 
Patients 
treated with 
CIST C/D 
Deepest PD 
during SPT 
(mm) 
Deepest PD 
at 10–year 
(mm) 
Implants with 
deepest PD 
> 6mm 
during SPT 
Implants with 
deepest PD 
> 6mm at 10-
year  
PHP 32 4 10.7% 4.2 ± 1.1   3.9 ± 0.7  6.6 %  1.7%  
Moderate PCP 42 5 27% 5.1 ± 1.8  4.4 ± 1.1  29.5%  15.9%  
Severe PCP 38 2 47.2% 5.5 ± 1.7  4.8 ± 1.2  45.6%  27.2%  
 
Statistical difference between 
PHP-moderate PCP 
PHP-severe PCP 
Moderate PCP-severe PCP 
 
   
 
p=0.10 
p=0.002 
p=0.07 
 
 
p= 0.001 
p= 0.0001 
p=0.016 
 
 
p=0.015 
p=  0.0001 
p=  0.009 
 
 
p=0.0005 
p=0.0001 
p=0.02 
 
 
p=0.005 
p=0.0001 
p=0.07 
Table 3b.  Number of patients treated with CIST C/D, deepest PD around solid implants and percentage of solid implants with 
deepest PD > 6mm (CIST= cumulative interceptive supportive therapy).  
 
 
 
Patients  
at 
baseline 
Patients 
drop-out 
Patients 
treated with 
CIST C/D 
Deepest PD 
during SPT 
around solid 
implants 
(mm) 
Deepest PD 
at 10–year 
around solid 
implants 
(mm) 
Solid 
implants with 
deepest PD 
> 6mm 
during SPT 
Solid 
implants with 
deepest PD 
> 6mm at 10-
year  
PHP 32 4 10.7% 4.2±0.9 4.0±0.7  5.8%  2.0%  
Moderate PCP 42 5 27% 5.1±1.7 4.4±1.1 30.1%  18.0%  
Severe PCP 38 2 47.2% 5.5±1.7 4.8±1.2 45.6%  27.2%  
 
Statistical difference between 
PHP-moderate PCP 
PHP-severe PCP 
Moderate PCP-severe PCP 
 
   
 
p=0.10 
p=0.002 
p=0.07 
 
 
p=0.002 
p=0.0001  
p=0.027 
 
 
p=0.029 
p=0.0001  
p=0.027  
 
 
p=0.0001 
p=0.0001 
p=0.04 
 
 
p=0.005 
p=0.0001 
p=0.19 
 
Table 4.   Clinical parameters around the implants at the 10-year follow-up in relation to adhesion to SPT in the three groups. 
 
Pl= plaque score (presence of dental plaque);  
BOP= presence of bleeding on probing;  
PD= probing depth. 
 
 
 
Adhesion  
to SPT 
Number of 
patients 
Pl  
 
BOP  
 
PD 
(mm) 
Teeth lost during 
SPT 
PHP 
No 4 11.4 ± 4.8% 11.4 ± 4.8% 3.0 ± 0.4 0.3 ± 0.5 
Yes 24 17.2 ± 2.7% 12.5 ± 2.4% 3.1 ± 0.5 1.0 ± 1.2 
Moderate PCP* 
No 11 38.5 ± 4.8% 50 ± 4.9% 4.3 ± 1.2 0.9 ± 0.8 
Yes 26 25 ± 2.7% 23 ± 2.7% 3.2 ± 0.6 1.5 ± 1.9 
Severe PCP** 
No 7 39.6 ± 7.1% 52.1 ± 7.2% 3.9 ± 0.7 2.7 ± 2.8 
Yes 29 20.3 ± 2.4% 27.2 ± 2.7% 3.9 ± 0.8 1.2 ± 1.1 
* Statistically significant difference for Pl (p= 0.011),  BOP (p= 0.0001) and PD (p= 0.008) between subjects adhering and not adhering to SPT. 
** Statistically significant difference for Pl (p= 0.003) and BOP (p= 0.0006) between subjects adhering and not adhering to SPT. 
 
Table 5. Number of patients treated with CIST C/D, deepest PD around implants and percentage of implants with deepest  
PD > 6mm in relation to adhesion to SPT in the three groups. 
 
 
 
Adhesion  
to SPT 
 
Number of 
patients 
Patients 
treated with 
CIST C/D 
Deepest PD 
during SPT 
(mm) 
Deepest PD 
at 10–year  
(mm) 
Implants with 
deepest PD > 
6mm during 
SPT 
Implants with 
deepest PD > 
6mm at 10-
year  
PHP 
No 4 0% 3.5 ± 0.5 3.5 ± 0.5 0  0 
Yes 24 12.5% 4.3 ± 1.1 4.0 ± 0.8 8.0% 2.1% 
Moderate PCP* 
No 11 36.4% 6.3 ± 2.0 5.2 ± 1.3 58.1% 42.3% 
Yes 26 23.1%  4.5 ± 1.3 4.0 ± 0.8 15.6% 4.8% 
Severe PCP** 
No 7 71.4% 7.2 ± 1.8 5.7 ± 1.1 88.9% 58.3% 
Yes 29 41.4%  5.1 ± 1.4 4.7 ± 1.2 34.7% 21.7% 
* Statistically significant difference for deepest PD during SPT (p= 0.0001), deepest PD at 10-year (p= 0.0001), percentage of implants with deepest PD ≥ 6mm during 
SPT (p= 0.001)  and of implants with deepest PD ≥ 6mm at 10-year (p= 0.001) between subjects adhering and not adhering to SPT. 
 
** Statistically significant difference for deepest PD during SPT (p= 0.0001), deepest PD at 10-year (p= 0.009), percentage of implants with deepest PD ≥ 6mm during 
SPT (p= 0.001) and of implants with deepest PD ≥ 6mm at 10-year (p= 0.01) between subjects adhering and not adhering to SPT. 
 
 
